Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 67
Filter
3.
Int J Infect Dis ; 104: 677-679, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33540127

ABSTRACT

Necrotizing soft tissue infection, with or without myositis, is classified among the most dangerous infectious emergencies in clinical practice. The authors report a case of an older diabetic woman who presented to the orthopedic service with right elbow pain after a small trauma with skin abrasion and released with an analgesic prescription. After 48h, she presented to the emergency room with a history of developing bullous and necrotic lesions in the upper right limb, hypotension, and numbness, with rapid and fatal evolution despite adequate clinical and surgical therapeutic support. Muscle biopsy showed necrotizing myositis. Blood culture was positive for Panton-Valentine leukocidin producing (PVL-positive) methicillin-resistant S. aureus. Although PVL has a strong epidemiologic association with Community-Acquired Methicillin-resistant Staphylococcus aureus (CA-MRSA) infections, it can also be found in CA-MSSA in the context of necrotizing pneumonia and skin and soft tissue infections. Although infrequent, CA-MRSA or CA-MSSA PVL+ infections should always be suspected in high-risk patients because they can rapidly evolve with severe, sometimes fatal complications.


Subject(s)
Diabetes Complications/mortality , Pyomyositis/etiology , Pyomyositis/mortality , Staphylococcal Infections/mortality , Diabetes Complications/microbiology , Fatal Outcome , Female , Humans , Methicillin-Resistant Staphylococcus aureus/genetics , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Methicillin-Resistant Staphylococcus aureus/physiology , Middle Aged , Pyomyositis/microbiology , Soft Tissue Infections/microbiology , Soft Tissue Infections/mortality , Staphylococcal Infections/microbiology
8.
BMJ Case Rep ; 20182018 Aug 23.
Article in English | MEDLINE | ID: mdl-30139787

ABSTRACT

A 73-year-old woman with medical history of diabetes and hypertension presented with right-sided back pain and night sweats of 1 month duration. On physical examination, there was costovertebral angle tenderness and her urinalysis was indicative for urinary tract infection. She was admitted and managed with intravenous antibiotics. On initial imaging, there was a right-sided retroperitoneal mass adjacent to right kidney. This was investigated further with MRI, which showed diffuse inflammation of right paraspinal muscles with two loculated abscesses. The abscesses were aspirated and the culture sent grew Streptococcus agalactiae (Group B Streptococcus) and the patient was treated with 6-week course of intravenous antibiotics.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Paraspinal Muscles/pathology , Pyomyositis/diagnosis , Streptococcal Infections/diagnosis , Urinary Tract Infections/complications , Abscess/diagnosis , Abscess/drug therapy , Abscess/surgery , Acute Disease , Aged , Diabetes Mellitus, Type 2/complications , Female , Humans , Magnetic Resonance Imaging , Pyomyositis/drug therapy , Pyomyositis/etiology , Streptococcal Infections/complications , Streptococcal Infections/drug therapy , Streptococcus agalactiae/isolation & purification , Urinary Tract Infections/drug therapy
10.
Infez Med ; 25(3): 270-273, 2017 Sep 01.
Article in English | MEDLINE | ID: mdl-28956546

ABSTRACT

Aspergillus myofasciitis is a rare infection of the muscles and their fascial sheaths that has been reported in patients with immune deficiencies of various kinds but, until now, not with chronic granulomatous disease (CGD). Patients affected by CGD are at high risk of invasive aspergillus infections. The case described involves a 14-year-old boy with a severe autosomal recessive CGD who was admitted to hospital with an Aspergillus myofasciitis of the left forearm. He was treated with liposomal amphotericin for 14 days and then with oral voriconazole for three months with an excellent clinical outcome. He did not evidence any recurrence in the following 30 months using itraconazole prophylaxis.


Subject(s)
Aspergillosis/etiology , Aspergillus fumigatus/isolation & purification , Fasciitis/etiology , Granulomatous Disease, Chronic/complications , Pyomyositis/etiology , Adolescent , Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Aspergillosis/drug therapy , Aspergillosis/microbiology , Aspergillosis/surgery , Combined Modality Therapy , Debridement , Drug Therapy, Combination , Fasciitis/drug therapy , Fasciitis/microbiology , Fasciitis/surgery , Forearm , Humans , Interferon-gamma/therapeutic use , Itraconazole/therapeutic use , Male , Pyomyositis/drug therapy , Pyomyositis/microbiology , Pyomyositis/surgery , Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use
13.
J Infect Chemother ; 23(4): 250-252, 2017 Apr.
Article in English | MEDLINE | ID: mdl-27847295

ABSTRACT

Pyomyositis is classified into two main types: tropical and non-tropical. Non-tropical pyomyositis occurs among various immunocompromised patients, and Staphylococcus aureus has been reported as the most common pathogen. Pyomyositis caused by Streptococcus pneumoniae is uncommon, and has not been previously reported after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Here, we report a unique case with pyomyositis caused by S. pneumoniae in the bilateral erector spinae muscles 34 months after allo-HSCT. The patient had an initial clinical response following the administration of intravenous benzylpenicillin potassium for 4 weeks. Although S. pneumoniae bacteremia is a rare bacterial infection after HSCT, the possibility of pyomyositis must be considered when a recipient develops S. pneumoniae bacteremia. Accurate diagnosis and the selection of appropriate antibiotics are necessary for the treatment of pyomyositis.


Subject(s)
Hematopoietic Stem Cell Transplantation/adverse effects , Pyomyositis/etiology , Pyomyositis/microbiology , Staphylococcal Infections/complications , Streptococcus pneumoniae/pathogenicity , Adult , Anti-Bacterial Agents/therapeutic use , Bacteremia/drug therapy , Bacteremia/etiology , Bacteremia/microbiology , Humans , Male , Pyomyositis/drug therapy , Staphylococcal Infections/drug therapy , Streptococcus pneumoniae/drug effects
14.
World J Surg Oncol ; 14: 116, 2016 Apr 19.
Article in English | MEDLINE | ID: mdl-27094880

ABSTRACT

BACKGROUND: Pyomyositis is a rare, subacute, deep pyogenic infection of the muscle tissue. This disease has been previously described in patients that were immunocompromised due to a hematological malignancy. CASE PRESENTATION: A 68-year-old man with a history of chronic myeloid leukemia was treated with imatinib. He was diagnosed with ascending colon cancer and underwent curative surgery. His postoperative course was uneventful, and he was healthy at 6 months after surgery, allowing for reinitiation of imatinib therapy. After the reinitiation of therapy, a computed tomography (CT) scan revealed a mass shadow in the right iliopsoas muscle. This lesion was clinically diagnosed as recurrent colon cancer with an abscess, which was resected surgically. A pathological examination uncovered both edema and inflammation. Two months after the second surgery, imatinib therapy was reinitiated; however, he again developed painful swelling and erythema in his right thigh. A CT scan revealed a similar shadow as described previously. He was then diagnosed with pyomyositis; he underwent incisional drainage and was administered linezolid. Following the treatment for pyomyositis, there was no cancer recurrence or evidence of any recurrent pyomyositis. CONCLUSIONS: Findings from this case suggest that both undergoing surgery and receiving imatinib therapy may modulate an individual's immune response, whereby the surgical site becomes more prone to infection and may predispose an individual to pyomyositis. The case report is followed by a discussion of the literature regarding this disease, including potential risk factors and the underlying pathogenesis.


Subject(s)
Antineoplastic Agents/adverse effects , Imatinib Mesylate/adverse effects , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/complications , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/surgery , Pyomyositis/etiology , Aged , Combined Modality Therapy , Humans , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy , Male , Neoplasm Staging , Prognosis , Pyomyositis/pathology
17.
BMJ Case Rep ; 20152015 Jun 08.
Article in English | MEDLINE | ID: mdl-26055607

ABSTRACT

A 26-year-old woman with paranoid schizophrenia was admitted to the medical intensive care unit with septic shock requiring intubation and mechanical ventilation. The source of septic shock was not identified despite obtaining CT of the chest/abdomen/pelvis, bronchoalveolar lavage and microbiological results for tracheal secretions, blood, urine and cervix. An indium-111 tagged white cell count scan was subsequently performed, revealing increased right anterior deltoid uptake. Owing to serial increases (up to 1310 U/L) in serum creatine kinase and a history of local intramuscular paliperidone injections for management of schizophrenia, surgical exploration was performed and identified necrotising skeletal muscle inflammation and extensive fat necrosis with an organising abscess, consistent with pyomyositis. A gram stain of purulent fluid revealed gram-positive cocci, but no organisms grew in culture. The patient recovered after 10 days of daptomycin and 7 weeks of wound care. Paliperidone injections were discontinued and oral risperidone was initiated.


Subject(s)
Antipsychotic Agents/administration & dosage , Injections, Intramuscular/adverse effects , Paliperidone Palmitate/administration & dosage , Pyomyositis/etiology , Schizophrenia/drug therapy , Adult , Anti-Bacterial Agents/therapeutic use , Antipsychotic Agents/therapeutic use , Daptomycin/therapeutic use , Female , Gram-Positive Cocci , Humans , Muscle, Skeletal/pathology , Necrosis , Paliperidone Palmitate/therapeutic use , Pyomyositis/microbiology , Risperidone/therapeutic use
19.
J Med Case Rep ; 9: 39, 2015 Feb 15.
Article in English | MEDLINE | ID: mdl-25889902

ABSTRACT

INTRODUCTION: Pyomyositis, though classically considered a tropical disease, has a variable geographic prevalence. Among the predisposing risk factors, immunodeficiency plays an important role. Pyomyositis has a tendency to mimic more commonly considered diseases, and a lack of familiarity with it is a cause of delayed diagnosis. CASE PRESENTATION: A 53-year-old South Asian man with newly diagnosed type 2 diabetes mellitus was referred to our medical unit in an advanced stage of the disease, which was complicated by sepsis and acute kidney injury. Failure of the referring unit to provide prompt treatment, as well as their delay in coming to a diagnosis, led to the patient's complicated state. Antibiotic therapy was initiated, and clinical stabilization was achieved with supportive measures. Following the patient's recovery from sepsis, his persistent leukopenia and anemia was suggestive of an underlying immunodeficiency, and a subsequent bone marrow biopsy revealed acute myeloid leukemia, M2 variant. Multi-disciplinary care was initiated by the medical, surgical and oncological teams. CONCLUSION: Awareness of tropical pyomyositis is lacking. Common predisposing behaviors and conditions should always be sought and investigated. Immunosuppressive state is an important predisposing factor in the pathogenesis of pyomyositis. Early antibiotic treatment is pivotal in management, and surgical intervention, when relevant, should not be delayed. Identifying one cause should not halt the search for others, as pyomyositis may herald underlying sinister diseases.


Subject(s)
Leukemia, Myeloid, Acute/diagnosis , Pyomyositis/etiology , Anti-Bacterial Agents/therapeutic use , Biopsy , Bone Marrow/pathology , Delayed Diagnosis , Diabetes Mellitus, Type 2/complications , Humans , Leukemia, Myeloid, Acute/complications , Male , Middle Aged , Pyomyositis/drug therapy
20.
Br J Hosp Med (Lond) ; 76(1): 18-24, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25585179

ABSTRACT

Panton-Valentine leukocidin-producing Staphylococcus aureus osteomyelitis is associated with multiple complications including multiple abscesses, deep vein thrombosis and fulminant sepsis. This article reviews the literature concerning this emerging threat which is currently under-recognized.


Subject(s)
Bacterial Toxins/metabolism , Exotoxins/metabolism , Leukocidins/metabolism , Osteomyelitis/diagnosis , Staphylococcal Infections/diagnosis , Staphylococcus aureus/metabolism , Anti-Bacterial Agents/therapeutic use , Child , Debridement , Humans , Osteomyelitis/complications , Osteomyelitis/therapy , Pyomyositis/etiology , Sepsis/etiology , Severity of Illness Index , Staphylococcal Infections/complications , Staphylococcal Infections/therapy , Venous Thrombosis/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...